Atlas Trials

Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia

Clinical trial NCT00012259 · COMPLETED

Trial details

NCT number
NCT00012259
Sponsor
Shire
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2000-12-11
Primary completion
2002-03-27
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.